| Literature DB >> 28369098 |
Kun Liu1, Li-Jun Tan1, Peng Wang2, Xiang-Ding Chen1, Li-Hua Zhu2, Qin Zeng1, Yuan Hu1, Hong-Wen Deng1,3.
Abstract
Osteoporosis is characterized by increased bone loss and deterioration of bone microarchitecture, which will lead to reduced bone strength and increased risk of fragility fractures. Previous studies have identified many genetic loci associated with osteoporosis, but functional mechanisms underlying the associations have rarely been explored. In order to explore the potential molecular functional mechanisms underlying the associations for osteoporosis, we performed integrative analyses by using the publically available datasets and resources. We searched 128 identified osteoporosis associated SNPs (P<10-6), and 8 SNPs exert cis-regulation effects on 11 eQTL target genes. Among the 8 SNPs, 2 SNPs (RPL31 rs2278729 and LRP5 rs3736228) were confirmed to impact the expression of 3 genes (RPL31, CPT1A and MTL5) that were differentially expressed between human subjects of high BMD group and low BMD group. All of the functional evidence suggested the important functional mechanisms underlying the associations of the 2 SNPs (rs2278729 and rs3736228) and 3 genes (RPL31, CPT1A and MTL5) with osteoporosis. This study may provide novel insights into the functional mechanisms underlying the osteoporosis associated genetic variants, which will help us to comprehend the potential mechanisms underlying the genetic association for osteoporosis.Entities:
Mesh:
Year: 2017 PMID: 28369098 PMCID: PMC5378394 DOI: 10.1371/journal.pone.0174808
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Expression quantitative trait locus (eQTL) analysis results between SNPs and the corresponding eQTL target genes.
| SNP | Chr | position | Context | Allele | Association | Gene1 | Gene2 | Implicated Gene | eQTL Gene | Effect | Score | Target | Regulome DB score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| rs2278729 | 2 | 101668856 | intron | A/G | 1.00E-07 | TBC1D8 | TBC1D8 | RPL31 | RPL31 | exon-QTL | 7.87 | monocytes | 1f |
| rs13182402 | 5 | 125918148 | intron | A/G | 2.00E-09 | ALDH7A1 | ALDH7A1 | ALDH7A1 | ALDH7A1 | eQTL | 45.14 | LCLS | 5 |
| rs227584 | 17 | 42225547 | missense | G/T | 9.00E-07 | C17orf53 | C17orf53 | SLC4A1 | C17orf53 | eQTL | 35.55 | LCLS | 6 |
| TMUB2 | eQTL | 55.47 | LCLS | ||||||||||
| rs228769 | 17 | 42193185 | intron | G/C | 2.00E-08 | HDAC5 | HDAC5 | SLC4A1 | C17orf65 | eQTL | 32.60 | monocytes | 4 |
| rs1007738 | 11 | 46849360 | intron | G/A | 7.00E-07 | CKAP5 | CKAP5 | CREB3L1 | MTCH2 | exon-QTL | 3.59 | LCLS | 1f |
| PHF21A | exon-QTL | 3.91 | LCLS | ||||||||||
| rs3736228 | 11 | 68201295 | missense | C/T | 6.00E-12 | LRP5 | LRP5 | LRP5 | CPT1A | eQTL | 20.78 | monocytes | 1f |
| MTL5 | eQTL | 13.26 | monocytes | ||||||||||
| rs1038304 | 6 | 151933175 | intron | A/G | 4.00E-11 | C6orf97 | C6orf97 | C6orf97 | C6orf97 | eQTL | 12.56 | monocytes | 6 |
| rs884205 | 18 | 60054857 | intergenic | T/G | 9.00E-09 | TNFRSF11A | RPL17P44 | TNFRSF11A | TNFRSF11A | eQTL | 1.00 | monocytes | 5 |
Note
1“Association P-value” are the results of PheGenI.
2“Gene 1” and “Gene 2” are the nearby genes physically located at two sides of the SNP.
3“Implicated genes" are the results from Gene Relationships Across Implicated Loci (GRAIL) analysis.
4"eQTL gene", "Effect", "Score", "Target" are the result of eQTL analysis. Score = −log10(P-value). The P-values represented the differences of gene expression of the different genotypes.
5“exon-QTL”: quantified reads for known exons by RNA sequencing against SNPs. All the eQTL genes have cis-effect.
6"RegulomeDB Score" is a scoring scheme of RegulomeDB and represents the source of supporting evidence. Among those, "1f" refers to the evidence from "eQTL + TF binding/DNase peak","4" refers to TF binding + DNase peak, "5" refers to TF binding or DNase peak, "6" refers to the evidence from "other"LCLs: lymphoblastoid cell lines.
Differential expression analysis for eQTL target genes in OP-related cells groups.
| Sample | S1 | S2 | S3 | |||
|---|---|---|---|---|---|---|
| GSE7158 | GSE2208 | GSE13850 | ||||
| osteoporosis | osteoporosis | osteoporosis | ||||
| Circulating Monocytes | Circulating Monocytes | Circulating B Lymphocytes | ||||
| 12:14 | 9:10 | 10:10 | ||||
| Affymetrix Human Genome U133 Plus 2.0 | Affymetrix Human Genome U133A Array | Affymetrix Human Genome U133A Array | ||||
| 241017_at | 4.73E-02 | 200962_at | 1.18E-01 | 200962_at | 5.42E-03 | |
| 203633_at | 1.31E-01 | 203633_at | 4.55E-01 | 210688_s_at | 1.56E-02 | |
| 238246_at | 1.21E-01 | N/A | N/A | 219786_at | 4.83E-02 | |
Note
1GSE NO: Gene Expression Omnibus Number (GSE7158[26], GSE2208[27], GSE13850[28]).
2Sample size: Low BMD:High BMD.
3N/A: Not available.
4We only listed the most significant expression results of probes if one gene has multiple detected probes.
Fig 1Predicted secondary structure of protein carrying either (A) rs3736228-C allele or (B) rs3736228-T allele. A:before missense mutation; B: after missense mutation. NOTE: The arrows point the position of the missense mutation. The 50 amino acids before and after missense mutations, which are: cdgfpecddqsdeegcpvcsaaqfpcargqcvdlrlrcdgeadcqdrsdeadcdaiclpnqfrcasgqcvlikqqcdsfpdcidgsdelmceitkppsdds and cdgfpecddqsdeegcpvcsaaqfpcargqcvdlrlrcdgeadcqdrsdevdcdaiclpnqfrcasgqcvlikqqcdsfpdcidgsdelmceitkppsdds, respectively.